GRIFOLS reported €3.24B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alcon AG ALC:SW 4.89B 498M
Amadeus IT AMS:SM € 2859.1M 507.5M
Amarin AMRN:US $ 719.12M 53.5M
Artemis Alpha ATS:LN 10.02M 2.53M
AstraZeneca AZN:LN 20.92B 1.73B
Bayer BAYN:GR 39.55B 1.3B
Essilor EI:FP 10.64B 1.44B
Fresenius FRE:GR € 18818M 816M
Fresenius Medical Care FME:GR € 8105M 65.61M
Galapagos GLPG:NA 4.53B 217.51M
Genmab GEN:DC 23.18B 439M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Hikma Pharmaceutical HIK:LN 2.14B 50M
Inditex ITX:SM 14.06B 456M
Merck MRK:GR € 12416M 1331M
Novartis NOVN:VX 38.14B 906M
William Demant Holding WDH:DC 7.89B 395M